Your browser doesn't support javascript.
loading
Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma.
Lythgoe, Hanna; Baildam, Eileen; Beresford, Michael W; Cleary, Gavin; McCann, Liza J; Pain, Clare E.
Afiliación
  • Lythgoe H; Department of Paediatric Rheumatology, Liverpool, UK.
  • Baildam E; NIHR Alder Hey Clinical Research Facility, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • Beresford MW; Department of Women's and Children's, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Cleary G; Department of Paediatric Rheumatology, Liverpool, UK.
  • McCann LJ; Department of Paediatric Rheumatology, Liverpool, UK.
  • Pain CE; NIHR Alder Hey Clinical Research Facility, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Rheumatology (Oxford) ; 57(2): 398-401, 2018 Feb 01.
Article en En | MEDLINE | ID: mdl-29077971
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerodermia Localizada / Fármacos Dermatológicos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Evaluation_studies / Observational_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerodermia Localizada / Fármacos Dermatológicos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Evaluation_studies / Observational_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido